Phenotypes of coronary microvascular obstruction phenomenon (no-reflow) during percutaneous coronary interventions in myocardial infarction

QR Code

Phenotypes of coronary microvascular obstruction phenomenon (no-reflow) during percutaneous coronary interventions in myocardial infarction

Objective: using the clustering method, to determine and describe the clinical and pathogenetic phenotypes of the coronary microvascular obstruction phenomenon (CMVO) that occurs during percutaneous coronary interventions (PCI) in patients with myocardial infarction (MI).Materials and methods: the s...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Frolov, I. A. Frolov, N. D. Ulanova, I. G. Pochinka, K. V. Kuzmichev, A. S. Mukhin, E. G. Sharabrin
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2024-01-01
Series:	Бюллетень сибирской медицины
Subjects:	no-reflow phenomenon myocardial infarction percutaneous coronary intervention cluster analysis classification
Online Access:	https://bulletin.ssmu.ru/jour/article/view/5430
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic value of no-reflow phenomenon in myocardial infarction: the role of the severity of ischemic damage
by: A. A. Frolov, et al.
Published: (2025-01-01)

NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01)

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

Predictors of the no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction due to stenotic coronary artery disease
by: O. O. Khaniukov, et al.
Published: (2025-04-01)

Intracoronary epinephrine and verapamil in the refractory no-reflow phenomenon in patients with acute myocardial infarction
by: S. V. Dil, et al.
Published: (2022-01-01)

Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
by: E. V. Konstantinova, et al.
Published: (2024-03-01)

Effectiveness of deferred coronary artery stenting in the prevention of no-reflow in patients with acute ST-segment elevation myocardial infarction
by: A. V. Azarov, et al.
Published: (2021-03-01)

PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON
by: E. V. Vyshlov, et al.
Published: (2015-02-01)

The role of microvascular obstruction and intramyocardial hemorrhage in reperfusion injury to the heart
by: К. V. Zavadovsky, et al.
Published: (2024-04-01)

The no-reflow phenomenon: current treatment and prevention strategies
by: S. V. Dil, et al.
Published: (2025-04-01)

Delayed endovascular surgery in patients with acute ST-segment elevation myocardial infarction due to massive culprit arterial thrombosis in the prevention of slow/no-reflow phenomenon
by: A. V. Azarov, et al.
Published: (2021-09-01)

Thrombolysis for Prevention of Cerebral No-Reflow After Cardiopulmonary Resuscitation
by: K. -A. Hossmann, et al.
Published: (2009-04-01)

Advances in Pathophysiology and Novel Therapeutic Strategies for Coronary No-Reflow Phenomenon
by: Hubert Borzuta, et al.
Published: (2025-07-01)

Thrombus aspiration in patients with ST-segment elevation myocardial infarction: a literature review
by: V. V. Ryabov, et al.
Published: (2023-09-01)

Effect of late culprit coronary artery revascularization on prognosis of patients with ST-elevation myocardial infarction
by: A. A. Frolov, et al.
Published: (2020-09-01)

Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM
by: N. S. Kostritca, et al.
Published: (2024-07-01)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

THE INFLUENCE OF PLANNED PERCUTANEOUS CORONARY INTERVENTIONS ON MORTALITY IN TYUMEN REGION
by: V. A. Kuznetsov, et al.
Published: (2015-06-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Imaging features and percutaneous endoscopic interlaminar decompression of vacuum disc phenomenon-induced lumbosacral radiculopathy: case report
by: Longxiao Wu, et al.
Published: (2025-07-01)

Thrombosis prevention in percutaneous coronary interventions
by: V. P. Lupanov, et al.
Published: (2009-08-01)

Preliminary Study to Understand the Role of Gut Microbiota in Coronary Slow Flow Phenomenon (CSFP)
by: Tayfun Gurol, et al.
Published: (2025-07-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN ST ELEVATION MYOCARDIAL INFARCTION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. M. Polikutina, et al.
Published: (2017-12-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

The Application of Coronary Contrast Emptying Time in Diagnosing Coronary Slow Flow Phenomenon: A Serial Case Report
by: Yudhie Tanta, et al.
Published: (2023-01-01)

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01)

Recurrent ischemia after percutaneous coronary intervention
by: M. P. Malgina, et al.
Published: (1970-01-01)

Influence of Reflow Cycles of the Pb–Free/Pb Hybrid Assembly Process on the IMCs Growth Interface of Micro-Solder Joints
by: Xinyuan He, et al.
Published: (2025-05-01)

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Characteristic of microcirculatory changes in patients with primary Raynod's phenomenon by videocapillaroscopy
by: T A Nevskaya, et al.
Published: (2003-06-01)

Distal radial access as an alternative to conventional radial access in coronary angiography and percutaneous coronary interventions
by: A. V. Korotkikh, et al.
Published: (2025-01-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

Immediate and short-term outcomes of percutaneous coronary intervention in patients with stable and multivessel coronary artery disease, intolerant to coronary artery bypass grafting
by: Sh. Sh. Zaynobidinov, et al.
Published: (2025-05-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Application of a Nomogram Model in Predicting Postoperative Delirium Following Percutaneous Coronary Intervention
by: Yaxin Xiong, et al.
Published: (2025-06-01)

Superior Rectus Recession for Heimann–Bielschowsky Phenomenon
by: Shruti Nishanth, et al.
Published: (2025-04-01)